Found: 29
Select item for more details and to access through your institution.
Three-dimensional dynamics of mesothelin-targeted CAR.CIK lymphocytes against ovarian cancer peritoneal carcinomatosis.
- Published in:
- Cancer Immunology, Immunotherapy, 2025, v. 74, n. 1, p. 1, doi. 10.1007/s00262-024-03860-w
- By:
- Publication type:
- Article
VEGF blockade enhances the antitumor effect of BRAF<sup>V</sup><sup>600E</sup> inhibition.
- Published in:
- EMBO Molecular Medicine, 2017, v. 9, n. 2, p. 219, doi. 10.15252/emmm.201505774
- By:
- Publication type:
- Article
CAR-Based Strategies beyond T Lymphocytes: Integrative Opportunities for Cancer Adoptive Immunotherapy.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 11, p. 2839, doi. 10.3390/ijms20112839
- By:
- Publication type:
- Article
Cytokine Profiling of End Stage Cancer Patients Treated with Immunotherapy.
- Published in:
- Vaccines, 2021, v. 9, n. 3, p. 235, doi. 10.3390/vaccines9030235
- By:
- Publication type:
- Article
Alloreactivity and anti-tumor activity segregate within two distinct subsets of cytokine-induced killer (CIK) cells: implications for their infusion across major HLA barriers.
- Published in:
- International Immunology, 2008, v. 20, n. 7, p. 841, doi. 10.1093/intimm/dxn042
- By:
- Publication type:
- Article
Full chimaeric CAR.CIK from patients engrafted after allogeneic haematopoietic cell transplant: Feasibility, anti‐leukaemic potential and alloreactivity across major human leukocyte antigen barriers.
- Published in:
- British Journal of Haematology, 2023, v. 200, n. 1, p. 64, doi. 10.1111/bjh.18469
- By:
- Publication type:
- Article
Recent advances in the development of breast cancer vaccines.
- Published in:
- Breast Cancer: Targets & Therapy, 2014, v. 6, p. 159, doi. 10.2147/BCTT.S38428
- By:
- Publication type:
- Article
PARP1 expression drives the synergistic antitumor activity of trabectedin and PARP1 inhibitors in sarcoma preclinical models.
- Published in:
- Molecular Cancer, 2017, v. 16, p. 1, doi. 10.1186/s12943-017-0652-5
- By:
- Publication type:
- Article
Cytokine-induced killer (CIK) cells, successes and challenges: report on the first international conference dedicated to the clinical translation of this unique adoptive cell immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 2, p. 1, doi. 10.1007/s00262-023-03605-1
- By:
- Publication type:
- Article
Predictive Factors in Metastatic Melanoma Treated with Immune Checkpoint Inhibitors: From Clinical Practice to Future Perspective.
- Published in:
- Cancers, 2024, v. 16, n. 1, p. 101, doi. 10.3390/cancers16010101
- By:
- Publication type:
- Article
Baseline Values of Circulating IL-6 and TGF-β Might Identify Patients with HNSCC Who Do Not Benefit from Nivolumab Treatment.
- Published in:
- Cancers, 2023, v. 15, n. 21, p. 5257, doi. 10.3390/cancers15215257
- By:
- Publication type:
- Article
PARP1 Inhibitor and Trabectedin Combination Does Not Increase Tumor Mutational Burden in Advanced Sarcomas—A Preclinical and Translational Study.
- Published in:
- Cancers, 2021, v. 13, n. 24, p. 6295, doi. 10.3390/cancers13246295
- By:
- Publication type:
- Article
Recruitment, Infiltration, and Cytotoxicity of HLA-Independent Killer Lymphocytes in Three-Dimensional Melanoma Models.
- Published in:
- Cancers, 2021, v. 13, n. 10, p. 2302, doi. 10.3390/cancers13102302
- By:
- Publication type:
- Article
Pazopanib and Trametinib as a Synergistic Strategy against Osteosarcoma: Preclinical Activity and Molecular Insights.
- Published in:
- Cancers, 2020, v. 12, n. 6, p. 1519, doi. 10.3390/cancers12061519
- By:
- Publication type:
- Article
Immunotherapy Associated Pulmonary Toxicity: Biology Behind Clinical and Radiological Features.
- Published in:
- Cancers, 2019, v. 11, n. 3, p. 305, doi. 10.3390/cancers11030305
- By:
- Publication type:
- Article
Dual VEGFA/BRAF targeting boosts PD‐1 blockade in melanoma through GM‐CSF‐mediated infiltration of M1 macrophages.
- Published in:
- Molecular Oncology, 2023, v. 17, n. 8, p. 1474, doi. 10.1002/1878-0261.13450
- By:
- Publication type:
- Article
Fibroblasts Impair Migration and Antitumor Activity of NK-92 Lymphocytes in a Melanoma-on-Chip Model.
- Published in:
- Bioengineering (Basel), 2023, v. 10, n. 1, p. 52, doi. 10.3390/bioengineering10010052
- By:
- Publication type:
- Article
Met inhibition revokes IFNγ-induction of PD-1 ligands in MET-amplified tumours.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Cytokine Induced Killer cells effectively kill chemo-resistant melanoma cancer stem cells.
- Published in:
- 2015
- By:
- Publication type:
- Abstract
Analytic and Dynamic Secretory Profile of Patient-Derived Cytokine-Induced Killer Cells.
- Published in:
- Molecular Medicine, 2017, v. 23, p. 235, doi. 10.2119/molmed.2017.00084
- By:
- Publication type:
- Article
Biological and Exploitable Crossroads for the Immune Response in Cancer and COVID-19.
- Published in:
- Biomedicines, 2022, v. 10, n. 10, p. N.PAG, doi. 10.3390/biomedicines10102628
- By:
- Publication type:
- Article
Comparing T Cell Subsets in Broncho-Alveolar Lavage (BAL) and Peripheral Blood in Patients with Advanced Lung Cancer.
- Published in:
- Cells (2073-4409), 2022, v. 11, n. 20, p. 3226, doi. 10.3390/cells11203226
- By:
- Publication type:
- Article
EphA2 Expression in Bone Sarcomas: Bioinformatic Analyses and Preclinical Characterization in Patient-Derived Models of Osteosarcoma, Ewing's Sarcoma and Chondrosarcoma.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 11, p. 2893, doi. 10.3390/cells10112893
- By:
- Publication type:
- Article
Cellular Immunotherapy Targeting Cancer Stem Cells: Preclinical Evidence and Clinical Perspective.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 3, p. 543, doi. 10.3390/cells10030543
- By:
- Publication type:
- Article
DNA damage response and repair genes in advanced bone and soft tissue sarcomas: An 8- gene signature as a candidate predictive biomarker of response to trabectedin and olaparib combination.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.844250
- By:
- Publication type:
- Article
Efficacy of CAR-T immunotherapy in MET overexpressing tumors not eligible for anti-MET targeted therapy.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2022, v. 41, n. 1, p. 1, doi. 10.1186/s13046-022-02479-y
- By:
- Publication type:
- Article
MET Oncogene Targeting for Cancer Immunotherapy.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 11, p. 6109, doi. 10.3390/ijms25116109
- By:
- Publication type:
- Article
The combination of sorafenib and everolimus shows antitumor activity in preclinical models of malignant pleural mesothelioma.
- Published in:
- BMC Cancer, 2015, v. 15, n. 1, p. 1, doi. 10.1186/s12885-015-1363-1
- By:
- Publication type:
- Article
Adoptive immunotherapy against ovarian cancer.
- Published in:
- Journal of Ovarian Research, 2016, v. 9, p. 1, doi. 10.1186/s13048-016-0236-9
- By:
- Publication type:
- Article